Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio.
about
Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Localized and Advanced Prostate Cancer: A Systematic Review and Meta-AnalysisPrognostic Role of Neutrophil-to-Lymphocyte Ratio in Prostate Cancer: A Systematic Review and Meta-analysisCurrent Status of Hepatic Arterial Infusion ChemotherapyPretreatment Neutrophil to Lymphocyte Ratio as a Prognostic Predictor of Urologic Tumors: A Systematic Review and Meta-AnalysisImmune Infiltration and Prostate CancerPrognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical reviewNeutrophil-to-Lymphocyte Ratio Predicts PSA Response and Prognosis in Prostate Cancer: A Systematic Review and Meta-AnalysisAssessment of a prognostic model, PSA metrics and toxicities in metastatic castrate resistant prostate cancer using data from Project Data Sphere (PDS)Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials.Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?A robust blood gene expression-based prognostic model for castration-resistant prostate cancerBlood-based gene expression profiling in castrate-resistant prostate cancer.Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate CancerPretreatment Neutrophil-to-Lymphocyte Ratio: A Predictor of Advanced Prostate Cancer and Biochemical Recurrence in Patients Receiving Radical Prostatectomy.Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma.Elevated preoperative neutrophil-to-lymphocyte ratio is associated with poor prognosis in gastrointestinal stromal tumor patients.A Novel and Validated Inflammation-Based Score (IBS) Predicts Survival in Patients With Hepatocellular Carcinoma Following Curative Surgical Resection: A STROBE-Compliant Article.Association of the neutrophil-to-lymphocyte ratio and prostate cancer detection rates in patients via contemporary multi-core prostate biopsyPrognostic value of preoperative serum lactate dehydrogenase levels for resectable gastric cancer and prognostic nomograms.Prognostic value of pretreatment serum lactate dehydrogenase level in patients with solid tumors: a systematic review and meta-analysis.Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities.Prognostic, predictive and potential surrogate markers in castration-resistant prostate cancer.Prognostic role of lactate dehydrogenase in solid tumors: a systematic review and meta-analysis of 76 studies.Prognostic significance of neutrophil-to-lymphocyte ratio in prostate cancer: evidence from 16,266 patients.Regulation of prostate cancer progression by the tumor microenvironment.Lactate dehydrogenase predicts combined progression-free survival after sequential therapy with abiraterone and enzalutamide for patients with castration-resistant prostate cancer.High neutrophil-to-lymphocyte ratio predicts poor clinical outcome in patients with castration-resistant prostate cancer treated with docetaxel chemotherapy.Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxel.The prognostic significance of postoperative neutrophil-to-lymphocyte ratio after radical prostatectomy for localized prostate cancer.Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio.Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival.Prognostic impact of preoperative neutrophil-to-lymphocyte ratio after radical prostatectomy in localized prostate cancer.Evaluation of hematological markers in minor head trauma in the emergency room.Prognostic value of parameters derived from white blood cell and differential counts in patients receiving palliative radiotherapy.Neutrophils in cancer: prognostic role and therapeutic strategies.Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer.Fibrinogen and C-reactive protein score is a prognostic index for patients with hepatocellular carcinoma undergoing curative resection: a prognostic nomogram study.Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells.The optimal treatment of metastatic hormone-naive prostate cancer: abiraterone acetate or docetaxel?Platelet-lymphocyte and neutrophil-lymphocyte ratios are prognostic but not predictive of response to abiraterone acetate in metastatic castration-resistant prostate cancer.
P2860
Q26751553-33F5CA43-FFF5-43B1-8669-7857A9BE91FAQ26773406-3B2618B2-E94C-4D55-A63C-53B1B1A3C20AQ26775437-9D060DC4-1C3F-4CF7-A731-0B6A80F9DAACQ26786160-C301EBAB-FC1C-49AF-810F-5EBE1933D114Q26798412-2C4C21FA-0245-4CE3-8E6C-16CBB23D690CQ28073742-78A2E3AD-7455-4F70-B38F-6B25E9598B80Q28552296-4B9AB1BC-A878-4C25-8430-6595821DE5CBQ30000285-D5AC4E02-C0E9-462D-BB66-2A299DC25EF4Q30878925-93B74683-7D50-4D55-AB21-01CBDC98FF4BQ33913878-C641D6D6-51A3-4001-A863-6B88F2A266C9Q35752837-B0959C71-8140-41B2-8079-68B2A41C5E19Q35772012-04945ACD-351D-493D-9C19-8198D06CDE71Q35948297-5D477654-CBDC-460C-BB65-07A8419FAA60Q36195647-9A386BB6-2604-410B-9DEE-1F6592681B06Q36241273-A81C847B-D4D2-4786-89BB-126CC147589CQ36627492-DB243AF6-30D2-4E8A-AB45-6FC4CED835A4Q37206163-8947AD59-001A-4B5E-A92D-B3DE2C173F9AQ37415001-F73CCB21-9239-4833-8657-70C2650A66DFQ37457735-52A56421-0833-44D0-8FCB-BD7208617CDAQ37744341-FB6BAE16-5661-4017-A5B5-C75435FB4941Q38299932-13712B8B-9471-434C-949B-0AB3F607096EQ38438248-D74B6B85-83E9-40AE-AD31-1845EA4E9565Q38487988-86DF0190-9751-4870-B9E6-39B5CF26C1C3Q38623275-0AAC2234-562C-47CB-BAC4-8377D549FA2FQ38717262-480E7728-5964-4578-98DE-BF6DA99FE44EQ38756919-55DD3F6C-61F0-4243-A1EA-B293A61A7D4CQ38994309-042CB723-CA7A-4FAD-A70A-042066672E24Q39031750-5B356945-A487-497F-9507-AFBAC9D76CE1Q39041165-1CFD0FBC-A372-4749-B2DF-17753EF845D4Q39062109-AE9B1DC8-1558-4F78-8B71-F66184C4EA3AQ39195033-11AF587E-8358-44C5-8241-1DB6F2F5D0B2Q39651226-64842A8D-F966-4BAB-B972-0F5FDF324CB1Q40415897-B2A0ADC9-29FC-4A8C-9AD7-F726C8A24FC3Q41171241-4207EFEB-F24A-4259-981B-177FD6C81A2FQ41431390-63A072ED-8A08-4A9B-8F7D-334EC3C46F19Q41558890-BA0AA6FE-04C5-4A0D-87F0-0C3256184856Q47140323-DF030B9D-9981-46F7-A681-4B865DEEB9EAQ47563950-DA194766-76C3-4611-8D5F-2BDFF7878073Q47810258-4ED2DA35-8FA1-455E-B8E4-B58EC041A190Q48110694-AA60DE9C-8C75-42A3-9686-59331E7BEADC
P2860
Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Simple prognostic score for me ...... eutrophil-to-lymphocyte ratio.
@en
Simple prognostic score for me ...... eutrophil-to-lymphocyte ratio.
@nl
type
label
Simple prognostic score for me ...... eutrophil-to-lymphocyte ratio.
@en
Simple prognostic score for me ...... eutrophil-to-lymphocyte ratio.
@nl
prefLabel
Simple prognostic score for me ...... eutrophil-to-lymphocyte ratio.
@en
Simple prognostic score for me ...... eutrophil-to-lymphocyte ratio.
@nl
P2093
P2860
P50
P356
P1433
P1476
Simple prognostic score for me ...... neutrophil-to-lymphocyte ratio
@en
P2093
Arnoud J Templeton
Aurelius Omlin
Carmel Pezaro
Francisco E Vera-Badillo
Ian F Tannock
Johann S de Bono
Raya Leibowitz-Amit
P2860
P304
P356
10.1002/CNCR.28890
P407
P577
2014-07-03T00:00:00Z